New Biotech Partnering Forum opens for business
2 December 2003 - 4 December 2003
Austria
The CORDIA Partnering Forum is a unique opportunity to access an audience of leaders and decision-makers within the biotech/pharma industry and investor community. Selected companies will have:
· A 12 minute presentation followed by 5 minutes for Q&A's ,· A dedicated meeting room to utilise exclusively for the 3 days of the event ,· An on-line appointment-setting system,· Access to the Partnering Forum meeting area for the duration of the event,· Promotion on the CORDIA web site,· Entry in the Partnering Forum Catalogue and CD
Applications are open to a broad range of companies, from start-ups to quoted groups, across therapeutic areas and technologies. Each presentation will be showcased alongside comparable stage companies from across the globe. All sessions will be facilitated by experienced animators from large biotech/pharma companies or by life science investors.
A specialist panel will screen and select the presenting companies to ensure original and innovative candidates are awarded a presentation slot. Companies that have been selected will be asked to pay EUR500 in addition to the CORDIA delegate fee.
CORDIA Partnering Forum is sponsored by Pharmalicensing and Elsevier. For more information and a full programme of events, please visit: http://www.cordiaconvention.com(opens in new window)
,Contacts
For all countries except Germany, Austria and Switzerland:,Richard Anderson at the CORDIA Press Office, De Facto Communications plc,e-mail: r.anderson@defacto.com; tel: +44 (0) 207 496 3310
For Germany, Austria and Switzerland:,Till C. Jelitto at the CORDIA Press Office, PR & D,e-mail: jelitto@prd.at; tel: +43 1 505 70 44
,NOTES TO EDITORS:
The first convention of its kind in Europe, CORDIA - EuropaBio Convention2003 takes place from 2-4 December 2003 at the Messe Wien, Vienna, Austria.
CORDIA - EuropaBio Convention 2003, is the first Pan-European biotechnology Conference specifically tailored for the biotechnology sector. Through partnering, networking and exhibitions, it will explore and influence the issues impacting on bioscience growth across Europe including technology transfer, product development and commercialisation, regulation, capital and resourcing.
The Convention will be an opportunity to showcase science and technology innovations, as well as providing the European industry with an unprecedented critical mass for learning, networking and doing business.
CORDIA - EuropaBio Convention 2003 will provide an environment for small, medium and large life science and biotech companies in the sector, along with investors, regulators, policy-makers, contract service providers and advisors as well as entrepreneurial scientists and clinicians to meet up and explore the potential of their business together.
CORDIA 2003 is being organised by three partners; EuropaBio, the European Association for Bioindustries, Technomark the specialist life science consulting and investment group and Reed Exhibitions, the world's largest event organiser. EuropaBio represents about 35 member companies operating worldwide and 22 national biotechnology associations with over 1200 SME members. Industry representatives, financiers, regulators, patients, NGO's, and politicians have all been involved in preparations to date to ensure relevant, high-level conference topics and seminars.
Pharmalicensing - the leading online marketplace for biopharma partnering
Pharmalicensing is the leading global marketplace for biopharma business development and partnering.
For licensors:,Pharmalicensing helps innovators market their licensing opportunities to decision makers at licensee organisations worldwide
For licensees:,Pharmalicensing facilitates global pharmaceutical/biotechnology companies, investors, and research organisations in identifying, tracking and securing of technology opportunities, actively communicating licensing needs, and forming better partnerships
For further information, visit http://www.pharmalicensing.com(opens in new window)
Email now for further information on how your company can benefit from participation at pharmalicensing.com e-mail: sales@pharmalicensing.com
Elsevier Life Sciences - now incorporating MDL Information Systems Inc., the leader in discovery informatics - offers a range of products and services that address the needs of corporate research and development. With original research and review journals, A&I databases and web and software application solutions we can meet your information needs at each step of your research. Visit Elsevier Life Sciences' booth and discover how we can enhance your research.
http://www.elsevierlifesciences.com,http://www.sciencedirect.com,http://www.mdl.com
· A 12 minute presentation followed by 5 minutes for Q&A's ,· A dedicated meeting room to utilise exclusively for the 3 days of the event ,· An on-line appointment-setting system,· Access to the Partnering Forum meeting area for the duration of the event,· Promotion on the CORDIA web site,· Entry in the Partnering Forum Catalogue and CD
Applications are open to a broad range of companies, from start-ups to quoted groups, across therapeutic areas and technologies. Each presentation will be showcased alongside comparable stage companies from across the globe. All sessions will be facilitated by experienced animators from large biotech/pharma companies or by life science investors.
A specialist panel will screen and select the presenting companies to ensure original and innovative candidates are awarded a presentation slot. Companies that have been selected will be asked to pay EUR500 in addition to the CORDIA delegate fee.
CORDIA Partnering Forum is sponsored by Pharmalicensing and Elsevier. For more information and a full programme of events, please visit: http://www.cordiaconvention.com(opens in new window)
,Contacts
For all countries except Germany, Austria and Switzerland:,Richard Anderson at the CORDIA Press Office, De Facto Communications plc,e-mail: r.anderson@defacto.com; tel: +44 (0) 207 496 3310
For Germany, Austria and Switzerland:,Till C. Jelitto at the CORDIA Press Office, PR & D,e-mail: jelitto@prd.at; tel: +43 1 505 70 44
,NOTES TO EDITORS:
The first convention of its kind in Europe, CORDIA - EuropaBio Convention2003 takes place from 2-4 December 2003 at the Messe Wien, Vienna, Austria.
CORDIA - EuropaBio Convention 2003, is the first Pan-European biotechnology Conference specifically tailored for the biotechnology sector. Through partnering, networking and exhibitions, it will explore and influence the issues impacting on bioscience growth across Europe including technology transfer, product development and commercialisation, regulation, capital and resourcing.
The Convention will be an opportunity to showcase science and technology innovations, as well as providing the European industry with an unprecedented critical mass for learning, networking and doing business.
CORDIA - EuropaBio Convention 2003 will provide an environment for small, medium and large life science and biotech companies in the sector, along with investors, regulators, policy-makers, contract service providers and advisors as well as entrepreneurial scientists and clinicians to meet up and explore the potential of their business together.
CORDIA 2003 is being organised by three partners; EuropaBio, the European Association for Bioindustries, Technomark the specialist life science consulting and investment group and Reed Exhibitions, the world's largest event organiser. EuropaBio represents about 35 member companies operating worldwide and 22 national biotechnology associations with over 1200 SME members. Industry representatives, financiers, regulators, patients, NGO's, and politicians have all been involved in preparations to date to ensure relevant, high-level conference topics and seminars.
Pharmalicensing - the leading online marketplace for biopharma partnering
Pharmalicensing is the leading global marketplace for biopharma business development and partnering.
For licensors:,Pharmalicensing helps innovators market their licensing opportunities to decision makers at licensee organisations worldwide
For licensees:,Pharmalicensing facilitates global pharmaceutical/biotechnology companies, investors, and research organisations in identifying, tracking and securing of technology opportunities, actively communicating licensing needs, and forming better partnerships
For further information, visit http://www.pharmalicensing.com(opens in new window)
Email now for further information on how your company can benefit from participation at pharmalicensing.com e-mail: sales@pharmalicensing.com
Elsevier Life Sciences - now incorporating MDL Information Systems Inc., the leader in discovery informatics - offers a range of products and services that address the needs of corporate research and development. With original research and review journals, A&I databases and web and software application solutions we can meet your information needs at each step of your research. Visit Elsevier Life Sciences' booth and discover how we can enhance your research.
http://www.elsevierlifesciences.com,http://www.sciencedirect.com,http://www.mdl.com